AGL 38.00 Decreased By ▼ -0.48 (-1.25%)
AIRLINK 191.00 Decreased By ▼ -12.02 (-5.92%)
BOP 9.21 Decreased By ▼ -0.96 (-9.44%)
CNERGY 5.83 Decreased By ▼ -0.71 (-10.86%)
DCL 8.60 Decreased By ▼ -0.98 (-10.23%)
DFML 36.20 Decreased By ▼ -3.82 (-9.55%)
DGKC 92.00 Decreased By ▼ -6.08 (-6.2%)
FCCL 33.90 Decreased By ▼ -1.06 (-3.03%)
FFBL 83.50 Decreased By ▼ -2.93 (-3.39%)
FFL 12.60 Decreased By ▼ -1.30 (-9.35%)
HUBC 119.01 Decreased By ▼ -12.56 (-9.55%)
HUMNL 13.50 Decreased By ▼ -0.52 (-3.71%)
KEL 5.20 Decreased By ▼ -0.41 (-7.31%)
KOSM 6.35 Decreased By ▼ -0.92 (-12.65%)
MLCF 42.00 Decreased By ▼ -3.59 (-7.87%)
NBP 59.74 Decreased By ▼ -6.64 (-10%)
OGDC 209.55 Decreased By ▼ -11.21 (-5.08%)
PAEL 36.75 Decreased By ▼ -1.73 (-4.5%)
PIBTL 8.01 Decreased By ▼ -0.90 (-10.1%)
PPL 188.10 Decreased By ▼ -9.78 (-4.94%)
PRL 37.65 Decreased By ▼ -1.38 (-3.54%)
PTC 23.20 Decreased By ▼ -2.27 (-8.91%)
SEARL 97.00 Decreased By ▼ -6.05 (-5.87%)
TELE 8.15 Decreased By ▼ -0.87 (-9.65%)
TOMCL 35.16 Decreased By ▼ -1.25 (-3.43%)
TPLP 13.47 Decreased By ▼ -0.28 (-2.04%)
TREET 22.61 Decreased By ▼ -2.51 (-9.99%)
TRG 52.45 Decreased By ▼ -5.59 (-9.63%)
UNITY 33.16 Decreased By ▼ -0.51 (-1.51%)
WTL 1.48 Decreased By ▼ -0.23 (-13.45%)
BR100 11,349 Decreased By -541.2 (-4.55%)
BR30 34,972 Decreased By -2384.1 (-6.38%)
KSE100 106,275 Decreased By -4795.3 (-4.32%)
KSE30 33,353 Decreased By -1555.7 (-4.46%)
World

EU to launch programme for 'second generation' Covid-19 vaccines

  • The EU Commission did not comment when contacted by AFP.
Published February 17, 2021

BRUSSELS: The EU will launch a programme to study Covid-19 variants and produce "second generation" vaccines against future strains, the bloc's president has said.

The "HERA incubator" programme, which begins Wednesday, will bring together the pharmaceutical industry, laboratories, health authorities and researchers, Ursula von der Leyen told French daily Les Echos on Tuesday.

"The virus has evolved and will continue to evolve," said a spokesperson for the bloc -- which has been criticised for its a slow rollout of vaccines so far.

"It is important we prepare for mutations."

Member states will also be asked to contribute additional funds so the EU can adapt and modify contracts already signed with vaccine providers and secure doses against future variants, Bloomberg reported.

The EU Commission did not comment when contacted by AFP.

With delays to deliveries of three already-authorised vaccines by AstraZeneca, Pfizer/BioNTech and Moderna, the EU's medicines regulator is under pressure from European capitals to speed more into service.

US pharmaceutical giant Johnson & Johnson is the latest to apply for authorisation for its coronavirus vaccine in the EU with a decision possible by the middle of March, Europe's drugs regulator said Tuesday.

Comments

Comments are closed.